• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-19A
Device Problems Patient-Device Incompatibility (2682); Biocompatibility (2886); Material Split, Cut or Torn (4008)
Patient Problem Heart Failure/Congestive Heart Failure (4446)
Event Date 03/30/2021
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
The patient was originally managed by the department of cardiology in (b)(6) hospital, but an aortic valve replacement(avr) surgery using a 19mm trifecta gt valve was conducted in another hospital((b)(6) hospital) on (b)(6) 2018, due to aortic stenosis, regurgitation and calcification.The patient was carried to (b)(6) hospital due to heart failure last week, and a semi-emergency re-do avr was performed on (b)(6) 2021.The trifecta gt valve was explanted, replaced with a 17mm sjm regent heart valve w/flex cuff.The explanted valve was discarded because the valve became fully damaged during its explant.There was a tear beside the stent post between the rcc and the lcc.Pannus formation and fusion with the aortic wall were confirmed, also.The surgeon attributed the issue to the valve.The patient state is confirming.
 
Manufacturer Narrative
An event of stenosis, regurgitation, pannus, calcification and fusion to the aortic wall were reported.The torn leaflet could not be confirmed.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
MDR Report Key11732156
MDR Text Key247509791
Report Number3008452825-2021-00244
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018205
UDI-Public05415067018205
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/18/2022
Device Model NumberTFGT-19A
Device Catalogue NumberTFGT-19A
Device Lot Number6397949
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received05/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
-
-